Post-Marketing Surveillance Data of Adverse Events Following Immunization with Human Rabies Vaccine — China, 2021–2024
China CDC Weekly · 2026 · 8 (17) · 495-500
DOI: 10.46234/ccdcw2026.079 ↗Kurz gefasst
Fachartikel in der Zeitschrift China CDC Weekly, 2026. Verfasst von Lina Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases (NITFID), Center for National Immunization Program, Chinese C…. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Themen: Patientensicherheit
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases (NITFID), Center for National Immunization Program, Chinese Center for Disease Control and Prevention & Chinese Academy of Preventi…
Zitieren
APA
Zhang, L., Li, K., Li, Y., Fan, C., Li, Y., Ren, M., Cao, L., Yu, W., & Yin, Z. (2026). Post-Marketing Surveillance Data of Adverse Events Following Immunization with Human Rabies Vaccine — China, 2021–2024. China CDC Weekly, 8(17), 495-500. https://doi.org/10.46234/ccdcw2026.079
Vancouver
Zhang L, Li K, Li Y, Fan C, Li Y, Ren M, et al. Post-Marketing Surveillance Data of Adverse Events Following Immunization with Human Rabies Vaccine — China, 2021–2024. China CDC Weekly. 2026;8(17):495-500. doi:10.46234/ccdcw2026.079
BibTeX
@article{Zhang2026,
author = {Zhang, Lina and Li, Keli and Li, Yan and Fan, Chunxiang and Li, Yuan and Ren, Minrui and Cao, Lei and Yu, Wenzhou and Yin, Zundong},
title = {Post-Marketing Surveillance Data of Adverse Events Following Immunization with Human Rabies Vaccine — China, 2021–2024},
journal = {China CDC Weekly},
year = {2026},
volume = {8},
number = {17},
pages = {495--500},
doi = {10.46234/ccdcw2026.079}
}
EUVIMED